- Cutting-edge research in Nanomedicine
- Innovative education and training in Nanomedicine
- Emphasis on diversity and broadening participation
- State-of-the art facilities and resources
- Establish partnerships with academia, industry, government and hospitals
- Local, National and Global impact
Nanomedicine Innovation Center Established
Nanomedicine Innovation Center EstablishedOctober 2, 2003
Nanomedicine Innovation Center established after open competition as an interdisciplinary Institute to catalyze and synergize materials research across Northeastern University.
SEM Facility Established
NSF IGERT Grant Awarded
NSF IGERT Grant AwardedOctober 2, 2005
National Science Foundation / National Cancer Institute IGERT nanomedicine grant awarded 2005 ‐ 2010.
NSF IGERT Grant Awarded
NSF IGERT Grant AwardedOctober 2, 2010
NSF/NCI IGERT Nanomedicine grant awarded 2010 – 2016.
NIH Core Facility designation
NIH Core Facility designationOctober 2, 2010
Designated as a National Institutes of Health, Center for Translational Cancer Nanomedicine core facility.
Nanomedicine AcademyOctober 2, 2014
Nanomedicine Academy established.
NSF IGE Grant Awarded
NSF IGE Grant AwardedOctober 2, 2014
NIH R25 CaNCURE grant awarded 2014 ‐ 2019.
Diversity AwardOctober 2, 2016
Biomedical Engineering Society Diversity Award to Srinivas Sridhar.
Nanomedicine Academy Certificate
Nanomedicine Academy CertificateAugust 1, 2017
Nanomedicine Academy Certificate program established.
MRI Clinical Trial
MRI Clinical TrialOctober 2, 2017
First‐in‐human clinical trial of QUTE‐CE MRA at MGH.
CaCNURE grant renewed
CaCNURE grant renewedOctober 2, 2019
NIH R25 CaNCURE grant awarded 2019 – 2024.
Industry, hospital and government partners
U.S. and international academic partners
Northeastern University faculty collaborators
Events 115 Snell Library -- NEU Tuesday, March 17, 2020 3:25 PM posted in: CaNCURE Seminar Su Ryon Shin, PhD. Assistant Professor of Medicine, Brigham and Women’s Hospital Read More Entrepreneurship Resources at Northeastern 24 East Village -- NEU Friday, March 13,...
Events Gene Edited and Engineered Cells: Next Generation of Cancer Therapeutics 119 Snell Libary -- NEU Friday, November 22, 2019 3:25 PM posted in: CaNCURE Seminar Khalid Shah, MS, PhD Vice Chair of Research, Brigham and Women’s Hospital Director, Center for Stem...
Jelena M. Janjic1,2,3 September 25, 2:50 pm, Snell Library 125 1Graduate School of Pharmaceutical Sciences, Duquesne University School of Pharmacy, Pittsburgh, PA, USA E-mail: firstname.lastname@example.org 2Chronic Pain Research Consortium, Duquesne University, Pittsburgh, PA, USA...